U.S. Markets
Eli Lilly (LLY) has acquired Kelonia Therapeutics for up to USD 7bln in cash, expected to close H2'26
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
